Tasimelteon: first global approval

scientific article published on March 2014

Tasimelteon: first global approval is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1013546030
P356DOI10.1007/S40265-014-0200-1
P698PubMed publication ID24610704

P50authorSohita DhillonQ102146188
P2093author name stringMadeleine Clarke
P2860cites workTherapeutics for Circadian Rhythm Sleep DisordersQ24600160
Melatonin and its analogs in insomnia and depressionQ28249175
Light, melatonin and the sleep-wake cycleQ33921442
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonistQ34186458
Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous systemQ34277688
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.Q34894399
Melatonin and its agonists: an updateQ46338504
Relationship between Napping and Melatonin in the BlindQ61055166
P433issue4
P921main subjecttasimelteonQ7687250
P304page(s)505-511
P577publication date2014-03-01
P1433published inDrugsQ3040094
P1476titleTasimelteon: first global approval
P478volume74

Reverse relations

cites work (P2860)
Q57446284Can we Fix a Broken Clock?
Q39040818Chronomedicine and type 2 diabetes: shining some light on melatonin
Q38271292Current Phase II investigational therapies for insomnia
Q39147457Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
Q34440574Melatonergic drugs in development
Q41181255New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
Q47557441New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
Q28387407Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial
Q91784560Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies
Q38247486Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder
Q34358480Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders

Search more.